All atropine Articles

The Role of Astigmatism in Myopia Development, Progression and Control

November 17, 2025 By Ashley Wallace Tucker, OD, FAAO, FSLS This scoping review investigates how astigmatism influences the onset, progression and control...

87

Response of Accommodation and Vergence Systems to Low Dose Atropine

November 1, 2025 By Kevin Chan, OD, MS, FAAO, IACMM The use of low-dose atropine on the accommodation and the vergence system...

666

Sydnexis Partner Santen Wins U.K. Approval for Ryjunea to Slow Childhood Myopia

November 6, 2025 DEL MAR, Calif. — Sydnexis‘ partner Santen has announced that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA)...

222

Sydnexis Shares Pivotal Data from STAR Trial at AMCP Nexus

November 4, 2025 DEL MAR, Calif. — At the Academy of Managed Care Pharmacy (AMCP) Nexus 2025, Sydnexis shared topline results from...

322

FDA Delays Approval of Sydnexis’ SYD-101 for Myopia, Asking for More Evidence

October 24, 2025 DEL MAR, Calif. — The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to...

487

Dr. Khanal, UAB Optometry Enter $25 Million NIH-Funded Study on Myopia

October 23, 2025 BIRMINGHAM, Ala. — The University of Alabama at Birmingham (UAB) School of Optometry, led by Safal Khanal, OD, PhD,...

731

0.01% Atropine Eye Drops in Children With Myopia and Intermittent Exotropia

October 1, 2025 By Nguyen Nguyen, MD, and Huy Tran, MD, PhD The underlying mechanism for myopia progression is uncertain. However, evidence...

507

Managing Juvenile-Onset Myopia When an Optical Biometer is Unavailable

With our expanding knowledge of juvenile-onset myopia, the accurate diagnosis and treatment of the disease is paramount to reduce the burden of...

325

Is Tapering Myopia Management Therapy Necessary Before Discontinuation?

September 1, 2025 By Dr. Gareth Lingham Morth Clinicians now have access to a range of myopia control therapies that have been...

623

Getting Started with Myopia Management

Impact of Low-Dose Atropine on Pupillary Diameter and Accommodative Amplitude

August 1, 2025 By Durgasri Jaisankar, PhD, Research Scientist at Brien Holden Vision Institute Low-dose atropine eye drops have demonstrated to be...

416

What’s Holding You Back? Addressing the Barriers in Implementing Myopia Management

Have you been dragging your feet or are you stalled in implementing myopia management? If so, you’re not alone. Jobson Optical Research...

370

Getting Started with Myopia Management

A Call to Action: Embrace Myopia Management as a Public Health Imperative

“The start is what stops most people.” –Don Shula Overall, only 23% of myopic patients aged 18 and under are receiving some...

577

Sydnexis Receives European Commission Approval of SYD-101

June 6, 2025 DEL MAR, Calif. — Sydnexis‘ proprietary low-dose atropine formulation, SYD-101, has received marketing authorization from the European Commission (EC)....

1.1K

iVeena Submits New Drug Application to FDA for Myopia Drug, IVMED-85

June 4, 2025 SALT LAKE CITY — iVeena Delivery Systems has submitted an investigational new drug (IND) application to the U.S. Food...

888

Research Highlights from Day One of ARVO 2025

The Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting is being held in Salt Lake City, Utah, from May...

1.0K

Efficacy and Safety of Low-Dose Atropine in Pre-Myopic Children

May 1, 2025 By Mahmoud Haddara, BSc, OD The use of topical low-dose atropine to slow progression in myopic children is well...

1.2K

How to Manage Progressive Myopia in Very Young Children

May 1, 2025 By Dr. Loren Rose The management of progressive myopia in young children has many specific challenges. Special considerations include,...

1.7K

Sydnexis Receives Positive Opinion in Europe for SYD-101

April 2, 2025 DEL MAR, Calif. — Sydnexis has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...

872

Implementation

How to Create Collaborative Relationships with Ophthalmologists

April 1, 2025 By Aamena Kazmi, OD, ABO Diplomate As myopia prevalence increases globally, collaborative relationships with ophthalmologists and optometrists is essential...

1.1K

Implementation

The Lipson/Koffler Myopia Management Treatment Protocol

March 17, 2025 By Michael Lipson, OD, and Bruce Koffler, MD The following is the second of two articles on the assessment...

1.4K

FDA Accepts New Drug Application for Sydnexis’ SYD-101

March 11, 2025 DEL MAR, Calif. — The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for...

626

Is There Power in Combining Treatment?

March 3, 2025 By Associate Professor Pauline Kang, BOptom, PhD, School of Optometry and Vision Science at UNSW in Sydney, Australia As...

1.0K

Synergistic Effect of Dual-Focus Soft Contact Lenses and 0.05% Atropine on Myopia Control

February 18, 2025 By Dwight Akerman, OD, MBA, FAAO, Dipl AAO, FBCLA, FIACLE Yum et al. investigated the synergistic effect of dual-focus...

911

Efficacy and Safety of Different Atropine Regimens for the Treatment of Myopia in Children

February 3, 2025 By Dwight Akerman, OD, MBA, FAAO, Dipl AAO, FBCLA, FIACLE The study “Efficacy and Safety of Different Atropine Regimens...

2.5K

How to Manage Progressive Myopia in Young Adults

February 3, 2025 By Eman Alzghoul, PhD, FIACLE, FBCLA Adult myopia progression is commonly observed in clinical practice, yet there is a...

710